D-0416-2015 Class II Terminated
FDA drug recall D-0416-2015 was initiated by Heritage Pharmaceuticals, Inc. on Feb 25, 2015 and is designated Class II. Reason for recall: Lack of Assurance of Sterility: Firm is recalling two injectable products due to concerns with quality control processes. The recall status is terminated (terminated Feb 26, 2016). Affected quantity: 24,344 vials.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 25, 2015
- Initiation Date
- Feb 25, 2015
- Termination Date
- Feb 26, 2016
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 24,344 vials
Product description
RIFAMPIN for Injection,USP, 600 mg per vial, Rx Only, Manufactured by: Emcure Pharmaceuticals Ltd., Hinjwadi, Pune, India Manufactured for: Heritage Pharmaceuticals Inc., Eatontown, NJ 07724 NDC 23155-340-31
Reason for recall
Lack of Assurance of Sterility: Firm is recalling two injectable products due to concerns with quality control processes.
Distribution pattern
Nationwide
Code information
Lot # VRIA002; Exp. 08/16, VRIA003; Exp. 09/16, VRIA004; Exp. 09/16
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0416-2015
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026